NZ's Fisher & Paykel sues Resmed in Australia over patent dispute
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.
Fisher & Paykel said it was seeking a range of legal remedies from the lawsuit, including banning the manufacture and sale of such Resmed products in Australia.
The company added its earnings forecast for fiscal 2018 remained unchanged.
Fisher & Paykel and California-based Resmed are engaged in patent disputes in several countries over medical devices used to treat respiratory conditions.
Fisher & Paykel had filed a case against Resmed in Britain in 2016 and said last month it could continue to sell its sleep apnea masks in the country after a UK court ruled Resmed's patent was invalid.
Resmed was not immediately available for a comment.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
Fisher & Paykel shares were about one per cent lower after the announcement, in a lower overall market in New Zealand. Resmed's Australia shares were down about one per cent while the larger Australian market traded flat.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
